Primary Febrile Neutropenia Prophylaxis for Patients Who Receive FEC-D Chemotherapy for Breast Cancer: A Systematic Review

PURPOSE: Despite widespread use of fluorouracil, epirubicin, cyclophosphamide, docetaxel (FEC-D) chemotherapy in breast cancer, the optimal strategy for primary febrile neutropenia (FN) prophylaxis remains unknown. A systematic review was therefore performed. METHODS: Embase, Ovid MEDLINE, PubMed, C...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandes, Ricardo, Mazzarello, Sasha, Stober, Carol, Ibrahim, Mohamed F.K., Dudani, Shaan, Perdrizet, Kirstin, Majeed, Habeeb, Vandermeer, Lisa, Shorr, Risa, Hutton, Brian, Fergusson, Dean, Gyawali, Bishal, Clemons, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180804/
https://www.ncbi.nlm.nih.gov/pubmed/30241156
http://dx.doi.org/10.1200/JGO.2016.008540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180804/
https://www.ncbi.nlm.nih.gov/pubmed/30241156
http://dx.doi.org/10.1200/JGO.2016.008540

Ejemplares similares